Plain-English translation of NCT05783869 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study looks at how heart and cardiovascular problems affect people living with bronchiectasis (a condition where airways in the lungs are permanently damaged). Researchers want to understand whether having both bronchiectasis and heart conditions makes symptoms worse, affects quality of life, and increases inflammation in the body. The study will compare two groups: people with bronchiectasis and heart problems, and people with bronchiectasis alone.
Many patients with bronchiectasis also have heart or cardiovascular problems, but doctors don't fully understand how these conditions interact or affect each other. This study aims to fill that gap by looking at whether heart conditions make bronchiectasis worse and whether they increase hospital stays and illness severity.
You likely qualify if…
You likely don't qualify if…
You will complete a quality-of-life questionnaire (SF-36) that asks about your symptoms and daily life. You will also have blood tests to measure inflammation markers. Researchers will track how often you need hospital care and monitor your symptoms over the study period. The study will compare your results with the other group to see how heart conditions affect your bronchiectasis.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Egypt
Aliae AR Mohamed Hussein [ahussein
Enrollment target
~30 participants
Started
March 2023
Primary completion
September 2026
Age range
18 Years – 80 Years
Last updated on clinicaltrials.gov in May 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Shaadad Shaddad, MD
Assuit University Faculty of Medicine
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.